Repeated transfusions of genetically modified cells are required in $SCID$ patients and in enzyme replacement therapy because

  • A
    Transfused cells have a limited life span
  • B
    Introduced gene has been mutated
  • C
    The enzyme required is degraded after $20$ days of transfusion
  • D
    Both $(a)$ and $(c)$

Explore More

Similar Questions

$ELISA$ is based on the principle of

The two polypeptide chains of human insulin are linked together by which of the following?

Which protein production was successfully introduced in $E. coli$?

In which of the following microorganisms can vaccines be produced using recombinant $DNA$ technology?

Which enzyme is used in the $ELISA$ test?

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo